{"id":"W2552384732","doi":"10.1182/blood.v114.22.2729.2729","title":"Sunitinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: Results of a Phase II Multi-Center Study of the NCIC Clinical Trials Group.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; University Health Network; Fraser Health; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Clinical endpoint; Phases of clinical research; Oncology; Chemotherapy regimen; Gastroenterology; Lymphoma; Clinical trial; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006284656,0.001722344,0.003322742,0.0005375802,0.0005114222,0.001052847,0.001045952,0.001612637,0.002413053],"category_scores_gemma":[0.001864237,0.0005777954,0.001750953,0.0005722948,0.0008975707,0.0009777877,0.0003507814,0.002346717,0.0006948747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001139717,"about_ca_system_score_gemma":0.001457886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00136165,"about_ca_topic_score_gemma":0.002522918,"domain_scores_codex":[0.998508,0.0009695574,0.00009285095,0.0001612342,0.0001182405,0.000150162],"domain_scores_gemma":[0.9980919,0.0004006624,0.0004164244,0.0001637191,0.000143109,0.0007841829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8224306,0.04581025,0.01380204,0.001385298,0.003550818,0.0003284536,0.0003250084,0.002251661,0.03163549,0.0001490549,0.004377499,0.07395384],"study_design_scores_gemma":[0.6567806,0.3094529,0.02732672,0.00004761926,0.00116236,0.0003782727,0.00005706011,0.0008486137,0.002178025,0.00008196206,0.001651381,0.00003448917],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879194,0.00529858,0.0004954056,0.0003525487,0.00009112933,0.003060803,0.001612609,0.0001073795,0.001062033],"genre_scores_gemma":[0.9859549,0.0031421,0.001794532,0.0006839497,0.0001774883,0.003589431,0.00342545,0.00004223869,0.001189951],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006284656,"threshold_uncertainty_score":0.0332368,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1099540988055508,"score_gpt":0.4067856245798212,"score_spread":0.2968315257742704,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}